Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRDM13 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ARHGAP23 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZNF511 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | LY6E | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | ASF1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SYT6 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
mRNA | EDA2R | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CEACAM1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | OPHN1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RAD54L2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |